# Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

> **NCT00553124** · PHASE3 · UNKNOWN · sponsor: **University Hospital Birmingham** · enrollment: 3400 (—)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** selenium
- **DRUG:** vitamin E
- **PROCEDURE:** biopsy
- **PROCEDURE:** chemoprevention
- **PROCEDURE:** cryopreservation
- **PROCEDURE:** cytology specimen collection procedure
- **PROCEDURE:** diagnostic procedure
- **PROCEDURE:** gene expression analysis
- **PROCEDURE:** immunohistochemistry staining method
- **PROCEDURE:** laboratory biomarker analysis
- **PROCEDURE:** medical chart review
- **PROCEDURE:** mutation analysis
- **PROCEDURE:** polymerase chain reaction
- **PROCEDURE:** quality-of-life assessment
- **PROCEDURE:** questionnaire administration
- **PROCEDURE:** study of socioeconomic and demographic variables

## Key facts

- **NCT ID:** NCT00553124
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 3400 (—)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553124, "Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00553124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*